Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or prevent transmission. Now, Yale School of Medicine researchers have taken… read more.
Two deadly infectious diseases, Ebola https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260834 and hantavirus https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260789, have made headlines in recent weeks as they pose serious threats to public health. They both require rigorous infection and prevention control… read more.
Merck, known as MSD outside of the United States and Canada, announced that the FDA has approved an expanded indication for Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) to include… read more.
A University of California, Riverside-led study of more than 3,200 emergency department (ED) patients across the United States found that while awareness of influenza vaccination is widespread, most adults seen in… read more.
Shingles vaccination reduces dementia risk, researchers reported on June 15, 2026 in the Annals of Internal Medicine. “Receipt of RZV [recombinant shingles vaccine] during admission to a skilled-nursing… read more.
Pediatric flu vaccines significantly reduce the number of childhood cases of influenza, new research from Harvard Medical School confirms. The findings, published on June 1 in JAMA Pediatrics, show… read more.
AbbVie has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of Maviret (glecaprevir/pibrentasvir), an oral… read more.
The European Medicines Agency (EMA) has unveiled a new communications effort designed to inform evidence-based decision-making. Vaccine Essentials offers healthcare professionals accessible summaries of how the quality, safety… read more.
A Kaiser Permanente study published by NEJM Catalyst Innovations in Care Delivery provides real-world data on a new approach to cervical cancer screening: giving patients the option to skip the… read more.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine Enflonsia (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns… read more.
With three people dead and 11 cases from the recent hantavirus outbreak on a cruise ship, UMD’s internationally renowned expert on airborne viruses, Dr. Don Milton, joins public… read more.
On 23 April 2026, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
